Peritoneal Cancer
A Single-Arm, Phase 2 Study of Neoadjuvant Carboplatin and Mirvetuximab Soravtansine in Subjects with FRα-Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer(M25-231)
- Details
ClinicalTrials.gov ID:
NCT06890338
Diagnosis Type:
NA
USOR Number:
- Address
,
P: